EMD-16680

Single-particle
2.7 Å
EMD-16680
3D View Gallery
Deposition: 10/02/2023
Map released: 21/02/2024
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-16680

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8cin summary report (pdf.gz) Map-8cin FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

BA.4/5-5 FAB IN COMPLEX WITH SARS-COV-2 BA.4 SPIKE GLYCOPROTEIN

EMD-16680

Single-particle
2.7 Å
EMD-16680
3D View Gallery
Deposition: 10/02/2023
Map released: 21/02/2024
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-Coronavirus-2 BA.4 Spike Glycoprotein in complex with BA.4/5-5 fab
Fitted models: 8cin

Deposition Authors: Duyvesteyn HME, Ren J, Stuart DI , Fry EE
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
Zhou D , Supasa P, Liu C, Dijokaite-Guraliuc A , Duyvesteyn HME, Selvaraj M, Mentzer AJ , Das R, Dejnirattisai W, Temperton N , Klenerman P , Dunachie SJ , Fry EE , Mongkolsapaya J , Ren J, Stuart DI , Screaton GR
(2024) Nat Commun , 15 , 2734 - 2734
PUBMED: 38548763
DOI: doi:10.1038/s41467-024-46982-6
ISSN: 2041-1723
Grant Support: